glp-1 dexcom G7 Sensor All-in-One Continuous Glucose Monitor STP-AT-012 Made for all types of diabetes The Dexcom G7 is the only integrated continuous glucose monitoring system that is cleared for use during pregnancy Should diabetics currently on GLP-1

Four key questions on the new wave of anti-obesity drugs

Lifestyle factors such as diet, tobacco use, excessive alcohol consumption, and obesity can also contribute to an increased risk

This same principle applies when comparing semaglutide, tirzepatide, and future medications such as retatrutide

In these settings, GLP-1 therapies are often positioned as part of a broader service package that includes coaching, lifestyle guidance, and ongoing support

Numerous generic firms have attempted to challenge patents on these products via paragraph IV certifications, but none has yet resulted in generic entry

References Latif W, Lambrinos KJ, Rodriguez R